Last reviewed · How we verify
Decitabine cycle 3
At a glance
| Generic name | Decitabine cycle 3 |
|---|---|
| Sponsor | ANRS, Emerging Infectious Diseases |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Decitabine cycle 3 CI brief — competitive landscape report
- Decitabine cycle 3 updates RSS · CI watch RSS
- ANRS, Emerging Infectious Diseases portfolio CI